`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`SAMSUNG BIOEPIS CO., LTD.,
`
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Patent Owner.
`__________________
`
`Case No.: IPR2023-00884
`
`U.S. Patent No. 11,253,572
`____________
`
`
`
`
`PETITIONER’S UNOPPOSED MOTION FOR PRO HAC VICE
`ADMISSION OF ELLIOT CHOI UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`IPR2023-00884
`U.S. Pat. 11,253,572
`
`
`
`Pursuant to 37 C.F.R. § 42.10(c) Petitioner Samsung Bioepis Co., LTD.
`
`(“Petitioner”) hereby files this motion for Elliot Choi to appear pro hac vice on its
`
`behalf before the Patent Trial and Appeal Board in this proceeding. As required by
`
`the Board’s Notice of Filing Date Accorded to Petition this motion for pro hac vice
`
`admission under 37 C.F.R. § 42.10(c) is being “filed in accordance with the ‘Order
`
`-- Authorizing Motion for Pro Hac Vice Admission’ in Case IPR2013-00639”
`
`(“IPR2013-00639 Order”) (Paper 7). Petitioner conferred with Patent Owner
`
`Regeneron Pharmaceuticals, Inc. (“Patent Owner”) and Patent Owner does not
`
`oppose the Motion for Admission pro hac vice.
`
`I.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`
`
`
`In accordance with 37 C.F.R. § 42.10(c), the Board may recognize counsel
`
`pro hac vice during a proceeding, subject to the conditions set forth therein, and any
`
`others that the Board may impose. Petitioner sets forth these facts in support of this
`
`motion:
`
`
`
`1.
`
`The undersigned contacted counsel for Patent Owner, Rebecca Weires,
`
`indicated that Patent Owner did not plan to oppose Mr. Choi’s admission pro hac
`
`vice.
`
`
`
`2.
`
`Lead counsel for Petitioner in this matter, Raymond Nimrod, is a
`
`registered practitioner.
`
`
`
`
`
`IPR2023-00884
`U.S. Pat. 11,253,572
`
`
`
`3.
`
`Accompanying this motion is Exhibit 1067, the Declaration of Elliot
`
`Choi in Support of Motion for Admission Pro Hac Vice in this proceeding. In his
`
`declaration, Mr. Choi attests, among other things, that he is an attorney at Quinn
`
`Emanuel Urquhart & Sullivan, LLP and is an experienced litigator. He is admitted
`
`to and a member in good standing of the State Bar of New York. Mr. Choi has been
`
`practicing law since 2018. He has had extensive experience litigating patent
`
`infringement cases over the past five years, including experience drafting pleadings,
`
`expert discovery, and specialized patent-related proceedings such as Markman
`
`briefing and invalidity contentions.
`
`
`
`4. Mr. Choi also has established familiarity with the subject matter at issue
`
`in this proceeding and related co-pending litigation. He has been involved with
`
`forming invalidity positions against U.S. Patent No. 11,253,572, the patent
`
`challenged in this IPR, and he has acquired a substantial understanding of the
`
`underlying legal and technological issues at stake in these proceedings. Mr. Choi has
`
`conducted a detailed review of the ’572 Patent, the relevant prior art, and the
`
`prosecution history and related patents. In fact, a significant amount of Mr. Choi’s
`
`time over the past year has been spent working on issues related to the ’572 Patent,
`
`related patents, and Patent Owner’s commercial product, Eylea®. Therefore, Mr.
`
`Choi has significant experience with the subject matter of this proceeding.
`
`
`
`
`
`
`
`IPR2023-00884
`U.S. Pat. 11,253,572
`
`II. Reasons for Granting the Motion
`
`
`
`The Board may recognize counsel pro hac vice during a proceeding “upon a
`
`showing of good cause, subject to the condition that lead counsel be a registered
`
`practitioner and to any other conditions as the Board may impose.” 37 C.F.R. §
`
`42.10(c). As set forth above, lead counsel in this proceeding, Raymond Nimrod, is
`
`a registered practitioner. Moreover, as set forth above and in the accompanying Choi
`
`declaration, Mr. Choi is a patent litigation attorney and has an established familiarity
`
`with the subject matter at issue in the proceeding.
`
`III. Conclusion
`
`
`
`For the foregoing reasons, Petitioner respectfully requests that the Board
`
`admit Elliot Choi pro hac vice in this proceeding.
`
`
`
`
`
`
`
`
`
`IPR2023-00884
`U.S. Pat. 11,253,572
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing Petitioner’s Power of
`
`Attorney Pursuant to 37 C.F.R. § 42.10(b) was served on January 3, 2024, to the
`
`following Counsel for Petitioner via email to Regeneron-MoFo-IPR@mofo.com.
`
`
`
`Date: January 4, 2024 Respectfully submitted,
`
`By: /s/ Raymond N. Nimrod
` Raymond N. Nimrod (Reg. No. 31,987)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Ave., 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 949-7100
`
`Attorney for Petitioner
`Samsung Bioepis, Co., LTD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`